Carregant...
Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
Follicular lymphoma (FL) is the most common type of indolent B-cell lymphoma. Twenty years ago, FL was considered an indolent lymphoma with a long survival time but without a high rate of complete remission with chemotherapies. The use of rituximab has improved the response and survival of patients...
Guardat en:
| Publicat a: | F1000Res |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
F1000 Research Limited
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6426075/ https://ncbi.nlm.nih.gov/pubmed/30906531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.16686.1 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|